From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in developed countries. The incidence of NAFLD in the general population is 30–38% deppending on the geographical area and the diagnostic method used. NAFLD is considered to be the liver manifestation of the metabolic synd...
Main Authors: | MUNTEANU, MIHAI ALEXANDRU, MIRCEA, PETRU ADRIAN |
---|---|
Format: | Online |
Language: | English |
Published: |
Iuliu Hatieganu University of Medicine and Pharmacy
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620846/ |
Similar Items
-
Current Management of NAFLD
by: MUNTEANU, MIHAI ALEXANDRU, et al.
Published: (2016) -
Molecular Mechanisms of NAFLD in Metabolic Syndrome
by: Martins, Maria João, et al.
Published: (2015) -
Comorbidities and Metabolic Derangement of NAFLD
by: Bang, Ki Bae, et al.
Published: (2015) -
NAFLD and Chronic Kidney Disease
by: Marcuccilli, Morgan, et al.
Published: (2016) -
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
by: Wainwright, Patrick, et al.
Published: (2016)